Myriad Genetics Ending Patent Dispute on Breast Cancer Risk Testing by ANDREW POLLACK

By ANDREW POLLACK

The biotech company, the subject of a 2013 Supreme Court ruling that genes cannot be patented, said it was giving up trying to stop other companies from offering tests.

Published: January 28, 2015 at 12:00AM

from NYT Business Day http://ift.tt/18rKSEd

from WordPress http://ift.tt/1CeTdaB

via Hadi Aboukhater